Co-Authors
This is a "connection" page, showing publications co-authored by Marco Loffi and Giuseppe Di Tano.
Connection Strength
1.447
-
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open Heart. 2020 11; 7(2).
Score: 0.228
-
[Impact of the COVID-19 pandemic on the management of heart failure outpatient clinics. Lessons during the lockdown restrictions]. G Ital Cardiol (Rome). 2020 Oct; 21(10):750-756.
Score: 0.226
-
[Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia]. Rev Esp Cardiol. 2020 Nov; 73(11):964-966.
Score: 0.225
-
Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia. Rev Esp Cardiol (Engl Ed). 2020 11; 73(11):964-966.
Score: 0.223
-
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment. Eur J Case Rep Intern Med. 2020; 7(7):001790.
Score: 0.222
-
Who was the culprit? Non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention and cangrelor infusion. Minerva Cardioangiol. 2019 Oct; 67(5):439-442.
Score: 0.211
-
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. Heart Vessels. 2021 Jan; 36(1):115-120.
Score: 0.056
-
Severe COVID-19 Pneumonia and Very Late Stent Thrombosis: a Trigger or Innocent Bystander? Korean Circ J. 2020 Jul; 50(7):632-633.
Score: 0.056